423 related articles for article (PubMed ID: 16770787)
1. Palliative goals, patient selection, and perioperative platelet management: outcomes and lessons from 3 decades of splenectomy for myelofibrosis with myeloid metaplasia at the Mayo Clinic.
Mesa RA; Nagorney DS; Schwager S; Allred J; Tefferi A
Cancer; 2006 Jul; 107(2):361-70. PubMed ID: 16770787
[TBL] [Abstract][Full Text] [Related]
2. [Splenectomy in 5 patients with idiopathic myelofibrosis].
Nozato A; Mizorogi F; Fukumi S; Watanabe H; Kobayashi M
Rinsho Ketsueki; 2001 Aug; 42(8):627-32. PubMed ID: 11579502
[TBL] [Abstract][Full Text] [Related]
3. Long-term analysis of the palliative benefit of 2-chlorodeoxyadenosine for myelofibrosis with myeloid metaplasia.
Faoro LN; Tefferi A; Mesa RA
Eur J Haematol; 2005 Feb; 74(2):117-20. PubMed ID: 15654901
[TBL] [Abstract][Full Text] [Related]
4. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia.
Mesa RA; Elliott MA; Tefferi A
Blood Rev; 2000 Sep; 14(3):121-9. PubMed ID: 10986148
[TBL] [Abstract][Full Text] [Related]
5. Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients.
Tefferi A; Mesa RA; Nagorney DM; Schroeder G; Silverstein MN
Blood; 2000 Apr; 95(7):2226-33. PubMed ID: 10733489
[TBL] [Abstract][Full Text] [Related]
6. Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction.
Barosi G; Ambrosetti A; Buratti A; Finelli C; Liberato NL; Quaglini S; Ricetti MM; Visani G; Tura S; Ascari E
Leukemia; 1993 Feb; 7(2):200-6. PubMed ID: 8426474
[TBL] [Abstract][Full Text] [Related]
7. Splenectomy in agnogenic myeloid metaplasia and postpolycythemic myeloid metaplasia. A study of 34 cases.
Brenner B; Nagler A; Tatarsky I; Hashmonai M
Arch Intern Med; 1988 Nov; 148(11):2501-5. PubMed ID: 3190384
[TBL] [Abstract][Full Text] [Related]
8. Thrombosis of the portal vein following splenectomy for myeloid metaplasia.
Broe PJ; Conley CL; Cameron JL
Surg Gynecol Obstet; 1981 Apr; 152(4):488-92. PubMed ID: 7209779
[TBL] [Abstract][Full Text] [Related]
9. Surgical and radiotherapeutic approaches for myelofibrosis with myeloid metaplasia.
Mesa RA; Tefferi A
Semin Oncol; 2005 Aug; 32(4):403-13. PubMed ID: 16202686
[TBL] [Abstract][Full Text] [Related]
10. Palliative splenectomy in myelofibrosis with myeloid metaplasia.
Mesa RA; Tefferi A
Leuk Lymphoma; 2001; 42(5):901-11. PubMed ID: 11697645
[TBL] [Abstract][Full Text] [Related]
11. Subtotal splenectomy for treatment of patients with myelofibrosis and myeloid metaplasia.
Petroianu A
Int Surg; 1996; 81(2):177-9. PubMed ID: 8912088
[TBL] [Abstract][Full Text] [Related]
12. Risks and benefits of splenectomy in myelofibrosis with myeloid metaplasia: a retrospective analysis of 26 cases.
Akpek G; McAneny D; Weintraub L
J Surg Oncol; 2001 May; 77(1):42-8. PubMed ID: 11344482
[TBL] [Abstract][Full Text] [Related]
13. [Role of splenectomy in the treatment of myelofibrosis].
Melikian AL; Kolosova LIu; Sokolova MA; Kovrigina AM; Silaev MA; Giliazitdinova EA; Gemdzhian ÉG; Karagiulian SR
Ter Arkh; 2013; 85(8):69-76. PubMed ID: 24137967
[TBL] [Abstract][Full Text] [Related]
14. Risks and benefits of splenectomy in myelofibrosis: an analysis of 39 cases.
Lafaye F; Rain JD; Clot P; Najean Y
Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):359-62. PubMed ID: 7892130
[TBL] [Abstract][Full Text] [Related]
15. Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia: a phase II trial.
Marchetti M; Barosi G; Balestri F; Viarengo G; Gentili S; Barulli S; Demory JL; Ilariucci F; Volpe A; Bordessoule D; Grossi A; Le Bousse-Kerdiles MC; Caenazzo A; Pecci A; Falcone A; Broccia G; Bendotti C; Bauduer F; Buccisano F; Dupriez B
J Clin Oncol; 2004 Feb; 22(3):424-31. PubMed ID: 14752066
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of the incidence and risk factors of postsplenectomy thrombosis of the portal, mesenteric, and splenic veins.
Stamou KM; Toutouzas KG; Kekis PB; Nakos S; Gafou A; Manouras A; Krespis E; Katsaragakis S; Bramis J
Arch Surg; 2006 Jul; 141(7):663-9. PubMed ID: 16847237
[TBL] [Abstract][Full Text] [Related]
17. [Splenectomy in immune thrombocytopenia and other hematological diseases].
Lanzi S; Lancini GP; Piardi T; Biasca F; Ottaviani GM; Rossi G; Pizzoccaro C; Pouchè A
G Chir; 1999; 20(11-12):479-86. PubMed ID: 10645065
[TBL] [Abstract][Full Text] [Related]
18. Splenectomy for massive splenomegaly: long-term results and risks for mortality.
Taner T; Nagorney DM; Tefferi A; Habermann TM; Harmsen WS; Slettedahl SW; Donohue JH
Ann Surg; 2013 Dec; 258(6):1034-9. PubMed ID: 23222031
[TBL] [Abstract][Full Text] [Related]
19. The role of splenectomy in myelofibrosis with myeloid metaplasia.
Barugola G; Cavallini A; Lipari G; Armatura G; Mantovani W; Baggio E
Minerva Chir; 2010 Dec; 65(6):619-25. PubMed ID: 21224796
[TBL] [Abstract][Full Text] [Related]
20. Splenectomy for agnogenic myeloid metaplasia.
Coon WW; Liepman MK
Surg Gynecol Obstet; 1982 Apr; 154(4):561-3. PubMed ID: 7064091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
